CXCL9 and B-cell non-Hodgkin lymphoma: In Addition, IL‐12 and Th1‐derived IFN‐γ exerted antitumor effects through the inhibitory effects of endogenous CXCL9 and CXCL10 on tumor vasculature in human Burkitt's lymphoma 51 and in B‐cell lymphoma 52, respectively.